BSB Pharma SRL
BSB Pharma reported total assets of 118,927 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Apr 2026).
The score of BSB Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +102 % Total assets +85 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BSB Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 06 Apr 2026
- Year ended 30 Sep 2024filed on 29 Apr 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
BSB Pharma's financial analysis
- Solvency67.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BSB Pharma
BSB Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0792.204.443
- VAT number
- BE0792204443
- Peppol
- Registered · 0208:0792204443 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Oct 2022
- Registered office
- 1082 Berchem-Sainte-Agathe
- Latest accounts
- 2025 · filed on 06 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
BSB Pharma (SRL) has been based in Berchem-Sainte-Agathe since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,660 € and equity of 79,924 €; its revenue is not published. Its solvency stands at 67.2%, above the median of its sector (37.8%).
Companies similar to BSB Pharma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Curasan Retail sale of pharmaceutical products Zwalm · balance sheet 103,974 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Panax Retail sale of pharmaceutical products Wemmel · balance sheet 99,320 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
Frequently asked questions about BSB Pharma
What is the revenue of BSB Pharma?
BSB Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BSB Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0792204443 for BSB Pharma, if the company is VAT-registered. Its company number (CBE) is 0792.204.443.
Where is the registered office of BSB Pharma?
According to the CBE register, the registered office of BSB Pharma is in 1082 Berchem-Sainte-Agathe.
What is the equity of BSB Pharma?
At the close of the 2025 financial year, the equity of BSB Pharma amounts to 79,924 €, a solvency of 67.2% of total assets.
Who manages BSB Pharma?
The register lists 1 active mandates at BSB Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BSB Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →